The paper analyzes the incidence of cervical cancer, evaluates various methods of its treatment, provides a historical overview of the problem and describes own experience of using high dose-rate brachytherapy in various combinations for 74 patients with cervical cancer...

<jats:p><jats:underline>Despite the undeniable successes of modern medicine, the problems of oncology and, in particular, oncogynecology are still unresolved. Thus, a 5-year overall survival rate for stage I ovarian cancer is 89 %, for stage IV – 17 %. Given that compla...

XV Oncological congress

ТКАНЕВЫЕ ГЕЛЬМИНТОЗЫ, ПОРАЖАЮЩИЕ МОЛОЧНУЮ ЖЕЛЕЗУ

<jats:p>This article describes the clinical and epidemiological characteristics of neuroendocrine tumors (NET) of the female reproductive system, including ovarian NET. We focus on current approaches to the classification of these tumors based on the embryogenesis and b...

Target therapy of ovarian cancer: hardship and progress

This literature review is devoted to luminal B breast cancer (BC). This phenotype accounts for 14–18 % of all BC cases and shows a significantly worse prognosis and higher risk of progression comparing to luminal A subtype. The article describes immunological and molecu...